Thrombus Formation at the Neck of Cerebral Aneurysms during Treatment with Guglielmi Detachable Coils

References

1. ↵
   Viñuela F, Duckwiler G, Mawad M. Guglielmi detachable coil embolization of acute intracranial aneurysm: perioperative anatomical and clinical outcome in 403 patients. J Neurosurg 1997;86:475–482

   PubMedWeb of Science
2. ↵
   Cognard C, Weill A, Castaings L, Rey A, Moret J. Intracranial berry aneurysms: angiographic and clinical results after endovascular treatment. Radiology 1998;206:499–510

   PubMedWeb of Science
3. ↵
   Debrun GM, Aletich VA, Kehrli P, Misra M, Ausman JI, Charbel F. Selection of cerebral aneurysms for treatment using Guglielmi detachable coils: the preliminary University of Illinois at Chicago experience. Neurosurgery 1998;43:1281–1297

   CrossRefPubMedWeb of Science
4. ↵
   Guglielmi G, Viñuela F, Dion J, Duckwiler G. Electrothrombosis of saccular aneurysms via endovascular approach: part 2. preliminary clinical experience. J Neurosurg 1991;75:8–14

   CrossRefPubMedWeb of Science
5. ↵
   Lempert TE, Malek AM, Halbach VV, Phatouros CC, Dowd CF, Higashida RT. Rescue treatment of acute parent vessel thrombosis with glycoprotein IIb/IIIa inhibitor during GDC coil embolization. Stroke 1999;30:693–695

   FREE Full Text
6. ↵
   Cronqvist M, Pierot L, Boulin A, Cognard C, Castaings L, Moret J. Local intraarterial fibrinolysis of thromboemboli occurring during endovascular treatment of intracerebral aneurysm: a comparison of anatomic results and clinical outcome. AJNR Am J Neuroradiol 1998;19:157–165

   Abstract
7. ↵
   Tateshima S, Murayama Y, Gobin YP, Duckwiler GR, Guglielmi G, Viñuela F. Endovascular treatment of basilar tip aneurysms using Guglielmi detachable coils: anatomic and clinical outcomes in 73 patients from a single institution. Neurosurgery 2000;47:1332–1342

   CrossRefPubMed
8. ↵
   Pelz DM, Lownie SP, Fox AJ. Thromboembolic events associated with the treatment of cerebral aneurysms with Guglielmi detachable coils. AJNR Am J Neuroradiol 1998;19:1541–1547

   Abstract
9. ↵
   White CJ, Ramee SR, Collins TJ, et al. Coronary thrombi increase PTCA risk: angioscopy as a clinical tool. Circulation 1996;93:253–258

   Abstract/FREE Full Text
10. ↵
    Uretsky BF, Denys BG, Counihan PC, Ragosta M. Angioscopic evaluation of incompletely obstructing coronary intraluminal filling defects: comparison to angiography. Cathet Cardiovasc Diagn 1994;33:323–329

    PubMed
11. ↵
    Guglielmi G, Viñuela F, Spetka I, Macellari V. Electrothrombosis of saccular aneurysms via endovascular approach: part 1. electrochemical basis, technique, and experimental results. J Neurosurg 1991;75:1–7

    CrossRefPubMedWeb of Science
12. ↵
    Horowitz M, Samson D, Purdy P. Does electrothrombosis occur immediately after embolization of an aneurysm with Guglielmi detachable coils? ANJR Am J Neuroradiol 1996;18:510–513

    Abstract
13. ↵
    EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 1997;336:1689–1696

    CrossRefPubMedWeb of Science
14. ↵
    Popma J, Prpic R, Lansky A, Piana R. Heparin dosing in patients undergoing coronary intervention. Am J Cardiol 1998;82:19P–24P

    PubMed
15. ↵
    Hirsh J, Warkentin TE, Raschke R, Granger C, Ohman EM, Dalen JE. Heparin and low-molecular weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest 1998;114:489S–510S

    CrossRefPubMedWeb of Science
16. ↵
    Verheugt FW, Liem A, Zijlstra F, Marsh RC, Veen G, Bronzwaer JGF. High dose bolus heparin as initial therapy before primary angioplasty for acute myocardial infarction: results of the Heparin in Early Patency (HEAP) pilot study. J Am Coll Cardiol 1998;31:289–293

    PubMedWeb of Science
17. ↵
    Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke: The PROACT II Study: a randomized controlled trial. JAMA 1999;282:2003–2011

    CrossRefPubMedWeb of Science
18. ↵
    Lincoff A, Tcheng J, Califf R, et al. Standard versus low-dose weight-adjusted heparin in patients treated with the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3) during percutaneous coronary revascularization. Am J Cardiol 1997;79:286–291

    CrossRefPubMedWeb of Science
19. ↵
    Boccara A, Benamer H, Juliard J, et al. A randomized trial of a fixed high dose vs a weight-adjusted low dose of intravenous heparin during coronary angioplasty. Eur Heart J 1997;18:631–635

    Abstract/FREE Full Text
20. ↵
    Hirsh J, Weitz JI. Thrombosis and anticoagulation. Semin Hematol 1999;36:118–132

    PubMed
21. ↵
    Mabry CD, Thompson BW, Read RC, Campbell GS. Activated clotting time monitoring of intraoperative heparinization: our experience and comparison of technique. Surgery 1981;90:889–895

    PubMedWeb of Science
22. ↵
    Wallace RC, Furlan AJ, Moliterno DJ, Stevens GH, Masaryk TJ, Perl J. Basilar artery rethrombosis: successful treatment with platelet glycoprotein IIB/IIIA receptor inhibitor. AJNR Am J Neuroradiol 1997;18:1257–1260

    Abstract
23. ↵
    Qureshi AI, Suri MF, Khan J, Fessler RD, Guterman LR, Hopkins LN. Abciximab as an adjunct to high-risk carotid or vertebrobasilar angioplasty: preliminary experience. Neurosurgery 2000;46:1316–1325

    CrossRefPubMedWeb of Science
24. ↵
    The Abciximab in Ischemic Stroke Investigators. Abxicimab in acute ischemic stroke: a randomized, double-blind, placebo-controlled, dose-escalation study. Stroke 2000;31:601–609

    Abstract/FREE Full Text
25. ↵
    Ng PP, Phatouros CC, Khangure MS. Use of glycoprotein IIb-IIIa inhibitor for a thromboembolic complication during Guglielmi detachable coil treatment of an acutely ruptured aneurysm. AJNR Am J Neuroradiol 2001;22:1761–1763

    Abstract/FREE Full Text
26. ↵
    Gold HK, Garabedian HD, Dinsmore RE, et al. Restoration of coronary flow in myocardial infarction by intravenous chimeric 7E3 antibody without exogenous plasminogen activators. Circulation 1997;95:1755–1759

    Abstract/FREE Full Text
27. ↵
    Reverter JC, Beguin S, Kessels H, Kumar R, Hemker HC, Coller BS. Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3. Antibody J Clin Invest 1996;98:863–874
28. ↵
    Zhu Y, Carmeliet P, Fay WP. Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance. Circulation 1999;99:3050–3055

    Abstract/FREE Full Text
29. ↵
    Tsao P, Forsythe M, Mousa S. Dissociation between the anti-aggregatory and anti-secretory effects of platelet integrin alpha IIb beta 3 (GPIIb/IIIa) antagonists, c7E3 and DMP728. Thromb Res 1997;88:137–146

    CrossRefPubMed
30. ↵
    Shatos MA, Doherty JM, Garabedian HD, Gold HK. ReoPro, antiplatelet antibody, enhances fibrinolytic potential of cultured arterial microvascular cells. Circulation 1996;94:I–702